BUZZ-Revolution climbs after report of Merck's up to $32 bln buyout talks

Reuters01-09
BUZZ-Revolution climbs after report of Merck's up to $32 bln buyout talks

** Shares of Revolution Medicines RVMD.O rise 15% to $123.49 premarket

** Merck MRK.N is in talks to buy Revolution in a deal worth up to $32 bln, FT reported on Thursday

** Analysts see over $10 billion in potential sales from Revolution’s RAS inhibitor portfolio by 2035

** FT report came a day after AbbVie ABBV.N denied a WSJ report that it was in advanced talks to acquire Revolution

** RVMD shares have surged about 34% since the WSJ report, adding about $5.3 billion to its market value, which stood near $20.8 billion, as of last close

** RVMD recently traded at -16.7 times fwd earnings, compared to its five-year avg of -9.8, per LSEG data

** RVMD gained more than 82% in 2025

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment